In this American Society of Clinical Oncology Connection Guest Commentary, Narjust Florez, Fatima Wilder Lauren Kiel, Rebekah Kaufman provide expert recommendations for Young Adults with Lung Cancer. – Florez Lab

Ruben Mesa: Glad to have the opportunity to discuss the FDA approval of momelotinib for patients with myelofibrosis in this interview with Pharmacy Times!

Gregg Margolis: If you can only read three things about health policy this week, I suggest…

Jemma Arakelyan: By publishing this letter in The Lancet, we wanted to bring the attention of doctors to the humanitarian crisis happening in Nagorno-Karabakh.

Jayasree Iyer: Generics and bio similars are key in achieving access to medicines for all.

Oscar Arrieta: Our study demonstrated that increased perilesional edema from brain metastases from NSCLC is a negative predictor of response to radiation therapy, short intracranial-PFS, and even worse OS.

Chris Friese: I appreciate the increased focus on health care worker deaths by suicide.

Jason Sheehan: Improving visual outcomes with the latest SRS and particle therapy approaches for skull-based tumors.

Johanna Joyce: We found that neutrophils are especially abundant in aggressive brain cancers – so what are they doing there?

Pashtoon Kasi: N-of-1 Precision Medicine: This story is very dear to my heart.